New Container Protects Bulk Frozen Biopharmaceuticals

WL Gore

Two growing trends in pharmaceuticals prompted the development of a new high-performance pouch that addresses the mechanical and purity challenges of packaging a liquid biologic or vaccine that requires low temperatures. The first is the growing trend of biologic drugs, which by nature require cold-chain handling to maintain stability and efficacy. The second reason is the market trend to centralized production of active ingredients, which often means shipping them in bulk to a separate location for manufacturing the final drug.

The Gore Sta-Pure Flexible Freeze Container maintains package integrity after freezing at ‑86 deg C. (‑123 deg F) and minimizes product loss due to package failure due to its durable design. In this Q&A, Joe Cintavey, product manager and specialist for the flexible freeze containers, explains more about how the Gore Sta-Pure Flexible Freeze Container addresses these challenges.

Originally published in Packaging Digest.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online